Stay updated with breaking news from Adel Nada. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MILAN, ITALY / ACCESSWIRE / May 9, 2023 / Alia Therapeutics, a Trento-based start-up specializing in innovative treatments for rare genetic diseases through next-generation gene editing technology, announced
GentiBio and BMS have signed a partnership agreement for developing new engineered Treg therapies for inflammatory bowel disease patients.
/PRNewswire/ -- GentiBio, Inc., an engineered regulatory T cells (Tregs) company, announced today that it has entered into a collaboration with Bristol Myers...
/PRNewswire/ -- GentiBio, Inc., a biotherapeutics company developing engineered regulatory T cell (Tregs) therapies for autoimmunity, autoinflammation and...